Literature DB >> 8430340

Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.

E Svedström1, K Parto, M Marttinen, P Virtama, O Simell.   

Abstract

Lysinuric protein intolerance (LPI) is an autosomal recessive disease caused by defective transport of the cationic amino acids lysine, arginine, and ornithine at the cell membrane. About 80 patients with LPI have been described worldwide, almost half of them in Finland. The symptoms appear in early childhood as a failure to thrive, growth retardation, muscular hypotonia, and episodes of stupor after protein-rich meals. Twenty-nine Finnish patients (current median age 24.8 years, range 3.7-47.9 years) over a mean follow-up time of 18.1 years (range 1.2-27.2 years) had 57 fractures after minor trauma, mostly in childhood. Their 440 skeletal radiographs showed severe osteoporosis (13/29), controversially abnormal thickening of cortex of the metacarpals (7/29), or thin cortices of the long bones (5/29), endplate impression of vertebrae (8/29), rickets-like metaphyses (2/29), or early destruction of cartilage (3/29). Skeletal maturation was delayed by 1-5 years in 23 of 24 patients. There was no correlation between fracture incidence, radiological bone structure, and delayed skeletal maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430340     DOI: 10.1007/bf00191519

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  16 in total

1.  Calcification in lysine deficiency.

Authors:  R C LIKINS; L A BAVETTA; A S POSNER
Journal:  Arch Biochem Biophys       Date:  1957-08       Impact factor: 4.013

2.  Skeletal abnormalities in homocystinuria.

Authors:  D P Brenton
Journal:  Postgrad Med J       Date:  1977-08       Impact factor: 2.401

3.  Skeletal fingings in homocystinuria: a collaborative study.

Authors:  H Schedewie; E Willich; H Gröbe; H Schmidt; K M Müller
Journal:  Pediatr Radiol       Date:  1973-03

4.  Basolateral-membrane transport defect for lysine in lysinuric protein intolerance.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

5.  Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism.

Authors:  J Perheentupa; J K Visakorpi
Journal:  Lancet       Date:  1965-10-23       Impact factor: 79.321

6.  The contributions of dietary protein and mineral to the healing of experimental fractures. A biomechanical study.

Authors:  T A Einhorn; F Bonnarens; A H Burstein
Journal:  J Bone Joint Surg Am       Date:  1986-12       Impact factor: 5.284

7.  Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts.

Authors:  D W Smith; C R Scriver; H S Tenenhouse; O Simell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  A collagen defect in homocystinuria.

Authors:  A H Kang; R L Trelstad
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Effects of semistarvation on skeletal homeostasis.

Authors:  R Shires; L V Avioli; M A Bergfeld; M D Fallon; E Slatopolsky; S L Teitelbaum
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

10.  Renal handling of diamino acids in lysinuric protein intolerance.

Authors:  O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  7 in total

1.  Nutrient intake in lysinuric protein intolerance.

Authors:  L M Tanner; K Näntö-Salonen; J Venetoklis; S Kotilainen; H Niinikoski; K Huoponen; O Simell
Journal:  J Inherit Metab Dis       Date:  2007-06-21       Impact factor: 4.982

2.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

Review 4.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

5.  Osteoporosis in lysinuric protein intolerance.

Authors:  K Parto; R Penttinen; I Paronen; L Pelliniemi; O Simell
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Lysinuric Protein Intolerance Presenting with Multiple Fractures.

Authors:  Jennifer E Posey; Lindsay C Burrage; Marcus J Miller; Pengfei Liu; Matthew T Hardison; Sarah H Elsea; Qin Sun; Yaping Yang; Alecia S Willis; Alan E Schlesinger; Carlos A Bacino; Brendan H Lee
Journal:  Mol Genet Metab Rep       Date:  2014

Review 7.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.